Urolithiasis Completed Phase 2 Trials for Silodosin (DB06207)

Also known as: Urolithiases / Urolithiasis (N20-N23) / Urolith

IndicationStatusPhase
DBCOND0032691 (Urolithiasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01144949Study of Silodosin to Facilitate Passage of Urinary StonesTreatment